Title |
A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study
|
---|---|
Published in |
Supportive Care in Cancer, March 2007
|
DOI | 10.1007/s00520-007-0248-5 |
Pubmed ID | |
Authors |
Rudolph M. Navari, Lawrence H. Einhorn, Patrick J. Loehrer, Steven D. Passik, Jake Vinson, John McClean, Naveed Chowhan, Nasser H. Hanna, Cynthia S. Johnson |
Abstract |
The purpose of this study is to determine the control of acute and delayed chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic chemotherapy (MEC) and highly emetogenic chemotherapy (HEC) with the combined use of palonosetron and olanzapine, and dexamethasone with the dexamethasone given on day 1 only. |
Mendeley readers
The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Taiwan | 1 | 2% |
Unknown | 55 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 10 | 18% |
Student > Bachelor | 10 | 18% |
Researcher | 8 | 14% |
Professor > Associate Professor | 7 | 13% |
Student > Doctoral Student | 3 | 5% |
Other | 8 | 14% |
Unknown | 10 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 25 | 45% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 11% |
Unspecified | 3 | 5% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Psychology | 2 | 4% |
Other | 5 | 9% |
Unknown | 13 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 August 2023.
All research outputs
#3,608,161
of 22,711,242 outputs
Outputs from Supportive Care in Cancer
#790
of 4,544 outputs
Outputs of similar age
#11,403
of 76,777 outputs
Outputs of similar age from Supportive Care in Cancer
#5
of 13 outputs
Altmetric has tracked 22,711,242 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,544 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 76,777 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.